Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Voros, P.
Right arrow Articles by Kammerer, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voros, P.
Right arrow Articles by Kammerer, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrology Dialysis Transplantation, Vol 13, Issue 11 2899-2904, Copyright © 1998 by Oxford University Press


ORIGINAL ARTICLES

Albuminuria after fetal pancreatic islet transplantation: a 10-year follow-up

P Voros, G Farkas, Z Lengyel, R Degi, L Rosivall and L Kammerer
Second Department of Medicine, Szent István Hospital, Budapest, Hungary; Department of Surgery, Department of Ophthalmology, Albert Szent-Gyorgyi University, Szeged, Hungary; Department of Pathophysiology, Nephrology Research and Training Centre, Semmelweis Medical University, Budapest, Hungary; Corresponding author at: Szent István Kórház, II Belgyógyászat, Nagyvárad tér 1, Budapest 1096, Hungary

Aim of the study: The prevention of diabetic nephropathy is as yet an unresolved issue. The aim of our study was to assess the effects of transplantation of long-term cultured and cryopreserved fetal pancreas islets on metabolic control and the development of diabetic nephropathy. Methods: Serum C-peptide, glucose, HbA1c, insulin requirements, urinary albumin excretion rate, and blood pressure of 10 insulin-dependent diabetic patients after transplantation were compared with a group of 27 insulin-dependent diabetic controls on insulin therapy only during a 10-year follow-up. Results: In the first year after transplantation mean insulin requirement decreased from 53.6±2.2 to 35.8±1.2 units. C-peptide levels appeared (0.55±0.08 ng/ml) and remained detectable throughout the follow-up.. Blood glucose and HbA1c were significantly (P<0.05) lower than in the controls. Mean albumin excretion rates of the transplant and the control groups during the follow up were 18.8±8.5 and 11.7±2.0, 16.6±6.6 and 14.0±2.3, 15.0±5.0 and 15.1±2.7, 15.3±7.5 and 20.4±4.2, 19.8±6.2 and 36.7±11.1, 11.7±3.6 and 51.3±14.6, 14.1±4.2 and 71.4±23.1, 22.7±8.6 and 92.0±28.1, 18.0±5.9 and 107.6±35.6, 21.7±11.0 and 101.5±29.2 &mgr;g/min respectively. From the 6th year the difference between the two groups was significant (P<0.001). In the transplant group initial mean systolic and diastolic blood pressure values were 132.0±3.3 and 81.5±1.5 mmHg, in the controls 130.4±3.4 and 79.6±1.6 mmHg respectively. Significant changes (P<0.05) of blood pressure during the follow-up or differences between the two groups were not observed. Conclusions: We conclude that fetal islet transplantation is effective in achieving good long-term diabetes control and in the prevention of diabetic nephropathy. Key words: albuminuria; diabetic nephropathy; diabetes mellitus; diabetes control; fetal pancreas islet transplantation
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.